These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2073819)

  • 1. Modulation of growth and differentiation of murine myeloma cells by immunoglobulin binding factors.
    Hoover RG; Roman S; Moore JS; Darby C; Müller S
    Curr Top Microbiol Immunol; 1990; 166():77-85. PubMed ID: 2073819
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
    Roman S; Moore JS; Darby C; Müller S; Hoover RG
    J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of FcR+ T cells and of IgG-BF in the control of myeloma cells.
    Teillaud JL; Brunati S; Elmalek M; Astier A; Nicaise P; Moncuit J; Mathiot C; Job-Deslandre C; Fridman WH
    Mol Immunol; 1990 Dec; 27(12):1209-17. PubMed ID: 2148806
    [No Abstract]   [Full Text] [Related]  

  • 4. A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cells.
    Amigorena S; Moncuit J; Fridman WH; Teillaud JL
    J Immunol Methods; 1987 Feb; 97(1):57-64. PubMed ID: 3546505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of IgE synthesis in the human myeloma cell line U-266 with an IgE binding factor from a human T-cell line.
    Nilsson G; Jernberg H; Hellman L; Ahlstedt S; Nilsson K
    Scand J Immunol; 1991 Dec; 34(6):721-6. PubMed ID: 1749921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.
    Teillaud JL; Mathiot C; Amigorena S; Brunati S; Moncuit J; Fridman WH
    Cancer Detect Prev; 1988; 12(1-6):115-23. PubMed ID: 3263193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte response to IgE regulatory factors in allergic patients during the course of immunotherapy.
    Tokushima M; Sanz ML; de las Marinas MD; Oehling A
    Allergol Immunopathol (Madr); 1990; 18(2):69-74. PubMed ID: 2371943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
    J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunotherapy on the production of IgE regulatory soluble factors. The response of normal lymphocytes.
    Tokushima M; Sanz ML; de las Marinas MD; Fernández JF; Oehling A
    Allergol Immunopathol (Madr); 1990; 18(2):63-8. PubMed ID: 2371942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for isotype-specific binding factors in the regulation of IgA- and IgG-specific responses by the anti/contrasuppressor T cell circuit.
    Ernst PB; Lee ST; Maeba J; Bienenstock J; Stanisz AM; Paraskevas F
    J Immunol; 1989 Sep; 143(5):1426-32. PubMed ID: 2569491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms that regulate idiotype expression in myeloma cells.
    Lynch RG; Milburn GL
    Ann N Y Acad Sci; 1983; 418():346-55. PubMed ID: 6231880
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the lymphocyte response and in the production of IgE regulatory factors in relation to the course of immunotherapy.
    Tokushima M; Sanz ML; de las Marinas MD; Oehling A
    Allergol Immunopathol (Madr); 1990; 18(3):127-33. PubMed ID: 2251973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte-mediated suppression of myeloma function in vitro. IV. Generation of effector suppressor cells specific for myeloma idiotypes.
    Abbas AK; Takaoki M; Greene MI
    J Exp Med; 1982 Apr; 155(4):1216-21. PubMed ID: 6174675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotype-specific suppression of IgE synthesis in a human myeloma cell line (U-266) by an IgE-binding protein derived from normal human peripheral blood cells.
    Jernberg H; Nilsson G; Ahlstedt S; Nilsson K
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):114-5. PubMed ID: 2707876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial issues and possible answers on the antigen-specific regulation of the IgE antibody response.
    Ishizaka K; Nakano T; Ishii Y; Liu YC; Mikayama T; Mori A
    Adv Exp Med Biol; 1996; 409():317-25. PubMed ID: 9095260
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.
    Peest D; Hölscher R; Weber R; Leo R; Deicher H
    Clin Exp Immunol; 1989 Feb; 75(2):252-7. PubMed ID: 2784737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty years with IgE: from the identification of IgE to regulatory factors for the IgE response.
    Ishizaka K
    J Immunol; 1985 Jul; 135(1):i-x. PubMed ID: 3873484
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of cell-derived factors in vitro which modulate IgE synthesis.
    Pfeiffer P; Rauschen I; Bujanowski J; König W
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):408-10. PubMed ID: 3570503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype-specific immunoglobulin binding factors of IgA and IgE.
    Yodoi J; Takami M; Doi T; Kawabe T; Yasuda K; Adachi M; Noro N
    Adv Exp Med Biol; 1987; 216A():75-80. PubMed ID: 2961212
    [No Abstract]   [Full Text] [Related]  

  • 20. High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.
    Sugie K; Nakano T; Tomura T; Takakura K; Mikayama T; Ishizaka K
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5278-83. PubMed ID: 9144228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.